ZipPrime is an R&D-based biotechnology company specializing in developing innovative technologies for nucleic acid molecule capturing, detection, and preservation. With a strong molecular biology background, the ZipPrime R&D team has successfully created a highly efficient method for targeting and capturing oligonucleotides, including fragile and rare circulating-free DNA molecules, at a single molecule level. Unlike traditional nucleic acid isolation and purification methods, which rely on size selection, ZipPrime's capturing technology utilizes magnetic particle-based primer structures that can easily target and capture each oligonucleotide molecule, offering a simple, accurate, and cost-effective solution.

These versatile magnetic particle-based structures also allow for reusable storage and enrichment of captured oligonucleotides, eliminating the need for complex devices or protocols. ZipPrime's intellectual property is protected by a patent portfolio, with a patent family based on a PCT application. In recognition of its innovative technology, ZipPrime was awarded the Horizon 2020 SME Instrument Phase 01 Grant and the Seal of Excellence certificate